(The Center Square) – The up to $100 million in state tax incentives for a $3 billion Eli Lilly expansion in Kenosha County isn’t the only tax incentive for the project.
The expansion is also part of a tax increment development zone primarily in Bristol with the details of that portion of the agreement still being worked about, according to Bristol Village Administrator Randy Kerkman.
The original Nexus medical manufacturing facility land was purchased from Pleasant Prairie in 2019 before the facility was sold to Eli Lilly in 2024. The Bristol land on an adjacent plot for the expansion was put in a TID in October 2024.
Those districts allow the property taxes that are paid on the increased value of the land to instead be collected by the district for future improvements rather than going into the general tax base.
Eli Lilly plans to add 750 jobs at the expanded facility in addition to the 130 current employees, which was used as reasoning for the $100 million in state tax credits.
The expansion will be used to expand the medical supply company’s injectable manufacturing for diabetes, obesity and future medicines.
Eli Lilly plans to use automation, including guided vehicles, robotics, and production equipment, at the expanded facility.
Digital automation will be embedded throughout the site to accelerate processes and increase accuracy, the company said.
